Robert Svatek, MD
Urology · San Antonio, TXNPI 1922216431
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $46,091 of the $51,248 with a category attached, or 89.9%. 10 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 45.1% of the total. Reporting peaked in 2019 at $26,059 and has fallen 99.6% since, to $111 in 2025. Among urology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $1348.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$23K
- Verity Pharmaceuticals Inc.$15K
- Urogen Pharma, Inc.$10K
- Photocure Inc$3K
- Medtronic$283
- Merck$111
- plus $205 from 4 others
Across 16 payments — averaging $47,906 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$767K
What the payments were for
- Consulting fees$46,09190%
- Speaking & faculty fees$2,5005%
- Travel & lodging$1,3553%
- Food & beverage$1,3033%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 18 | $23,103 |
| Verity Pharmaceuticals Inc. | 5 | $14,731 |
| Urogen Pharma, Inc. | 3 | $9,704 |
| Photocure Inc | 5 | $3,112 |
| Medtronic | 2 | $283 |
| Merck | 1 | $111 |
| Bayer | 1 | $83 |
| Boston Scientific | 1 | $71 |
| Intuitive Surgical | 1 | $36 |
| Cook Medical LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$51,248 in reported general payments places this provider in the 90th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 14 | $16,452 |
| Tamsulosin Hcl | 104 | $1,233 |
| Finasteride | 67 | $929 |
| Trospium Chloride | 25 | $903 |
| Ciprofloxacin Hcl | 20 | $114 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $112 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $79 |
Paid to pharmacies, not to this prescriber.
Other urology in San Antonio
- Daniel SaltzsteinSan Antonio$547K
- Leroy JonesSan Antonio$506K
- Jose de la CerdaSan Antonio$278K
- Naveen KellaSan Antonio$84K
- Christopher CantrillSan Antonio$73K
- Andrew von EschenbachMontgomery$3.2M
- Brian MazzarellaLakeway$1.2M
- Arun RaiHouston$920K
- Allen MoreyDallas$914K
- Donald GriffithHouston$732K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.